Gemmus Pharma's Series B Round

Gemmus Pharma raised a round of funding on May 13, 2014.

Gemmus Pharma is a biotechnology company that is developing therapeutics for influenza and other infectious diseases. The company's approach is to identify compounds which have completed at least Phas…

Articles about Gemmus Pharma's Series B Round: